Trends Rising Demand for Weight Management Solutions Advancements in Drug Formulations Integration of Digital Health Technologies Opportunities Innovations in Drug Delivery Systems Increasing Prevalence of Obesity and Diabetes Rising Investment in Diabetes and Obesity Research GLP-1 Drug Market Summary The Global GLP-1 Drug Market size was valued at USD 10.77 Billion in 2024, and the market is projected to grow from USD 12.19 Billion in 2025 to USD 42.0 Billion by 2035, registering a CAGR of 13.17% during the forecast period 20252035
:max_bytes(150000):strip_icc()/GettyImages-2246015697-1f1c65229d9d47fbb5df86e120ce93fc.jpg)
Individuals at greater risk of low blood sugar whilst taking retatrutide include: Those concurrently prescribed sulphonylureas (e.g., gliclazide, glibenclamide), which stimulate insulin release independently of blood glucose levels dose reduction is often required when initiating potent incretin-based therapies [16] [8] Patients using insulin therapy , where doses may need to be reduced as glycaemic control improves or caloric intake falls People with renal impairment , who may have a generally increased risk of hypoglycaemia, particularly if also taking insulin or sulphonylureas (note: the specific effect of renal impairment on retatrutide clearance has not yet been established, as no SmPC exists) Individuals who are fasting , following a very low-calorie diet, or who have significantly reduced their food intake a common occurrence given retatrutide's appetite-suppressing effects Those with a history of hypoglycaemia or hypoglycaemia unawareness Older adults, who may have reduced counter-regulatory responses to falling blood glucose The appetite suppression associated with retatrutide can lead to substantially reduced caloric intake, which whilst beneficial for weight loss may necessitate a review and reduction of concomitant glucose-lowering therapies

A phase 2 randomized controlled trial of personalized peptide vaccine immunotherapy with low-dose dexamethasone versus dexamethasone alone in chemotherapy-naive castration-resistant prostate cancer
A study recently revealed that fitspiration, the Other research warned that following the nutrition advice of 53 social media super-spreaders could put up to 24 million people at risk of serious health consequences